Peer-Reviewed Articles from Managed Care


The Appropriate Omalizumab Patient

Management of the uncontrolled asthma patient and case examples

Jill Karpel, MD; Donald A. Bukstein, MD; Robert LoNigro, MD


Applying the Planned Care Model To Intimate Partner Violence

Implementing what was formerly called the Chronic Care Model can improve an organization's response to this widespread problem

Therese Zink, MD, MPH; Karen Lloyd, PhD, LP; George Isham, MD; David J. Mathews, PsyD, LICSW; Terry Crowson, MD


The Use of Therapeutic Interchange for Biologic Therapies

Joseph Flood, MD, FACR; Charles Mihalik, PharmD, RPh; Renee R. Fleming, RPh, MBA; Bruce E. Strober, MD, PhD; Deborah R. Zucker, MD, PhD


Implementing Disease Management Programs for Type 2 Diabetes in Germany

Germany has been able to enroll more than a million people with type 2 diabetes in DM programs through legislation that created incentives for physicians and insurers

Heinz Nagel, MD; Thomas Baehring, PhD; Werner A. Scherbaum, MD, PhD


Compliance With Antithrombotic Guidelines: Current Practice, Barriers, and Strategies For Improvement

Deeply held, but not evidence-based, concerns about the possible risks of pharmacologic prophylaxis leave many patients at risk for DVT

Joseph A. Caprini, MD, MS, FACS, RVT; Thomas M. Hyers, MD, FCCP


When Overcrowding Paralyzes an Emergency Department

Changing the process and mindset of health care professionals was the key to reducing emergency department overcrowding

Joseph R. Twanmoh, MD, FACEP; Gail P. Cunningham, MD, FACEP


The Cost-Effectiveness of Omega-3 Supplements For Prevention of Secondary Coronary Events

Dietary supplementation with omega-3 fatty acids in U.S. males is associated with fewer cardiovascular fatalities and lower costs

Jordana K. Schmier, MA; Nancy J. Rachman, PhD; Michael T. Halpern, MD, PhD


The Cost Benefit to Health Plans of Pharmacotherapy for Alzheimer's Disease

As with other chronic diseases of aging, early diagnosis and pharmacologic therapy may reduce the costs for enrollees with Alzheimer's disease

David S. Geldmacher, MD


17 Alpha-Hydroxyprogesterone Caproate (17P) Usage in a Medicaid Managed Care Plan and Reduction in Neonatal Intensive Care Unit Days

Offering 17P as a benefit to pregnant women enrollees with a history of preterm delivery can reduce NICU days significantly for a Medicaid plan.

Mary V. Mason, MD, MBA; Kara M. House, BS, MBA; Cathy M. Fuest, RPh; Deborah R. Fitzgerald, RN; Bonnie J. Kitson, MBA


Evaluating the Nondrug Costs of Formulary Coverage Restrictions

Substantial nondrug costs result from switching prescribed medications in response to changes in insurance coverage, and many nonreimbursed costs shift to providers and patients.

Paul Abourjaily, PharmD; William A. Gouveia, MS; Harry P. Selker, MD, MSPH; Deborah R. Zucker, MD, PhD

more